Atropine for the treatment of childhood myopia: Changes after stopping atropine 0.01%, 0.1% and 0.5%

American Journal of Ophthalmology

Volumn 157, Issue 2, 2014, Pages

  Chia, Audrey ^a,b   Chua, Wei Han ^a,b   Wen, Li ^c,d   Fong, Allan ^a,b   Goon, Yar Yen ^b   Tan, Donald ^a,b,c,e  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE;

ACCOMMODATION; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOPIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PUPIL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VISUAL ACUITY;

ACCOMMODATION, OCULAR; ADMINISTRATION, TOPICAL; ATROPINE; AXIAL LENGTH, EYE; CHILD; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MYDRIATICS; MYOPIA; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; PUPIL; VISUAL ACUITY; WITHHOLDING TREATMENT;

EID: 84892563488     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.09.020     Document Type: Article

References (26)

1. H.V. Gimbel The control of myopia with atropine Can J Ophthalmol 8 4 1973 527 532
2. T.S. Kelly, C. Chatfield, and G. Tustin Clinical assessment of the arrest of myopia Br J Ophthalmol 59 10 1975 529 538
3. R.H. Bedrossian The effects of atropine on myopia Ophthalmology 86 5 1979 713 717
4. R.S. Brodstein, D.E. Brodstein, and R.J. Olson et al. The treatment of myopia with atropine and bifocals: a long-term prospective study Ophthalmology 91 11 1984 1373 1379
5. R.L. Brenner Further observations on use of atropine in the treatment of myopia Ann Ophthalmol 17 2 1985 137 140
6. A.C. Chou, Y.F. Shih, T.C. Ho, and L.L. Lin The effectiveness of 0.5% atropine in controlling high myopia in children J Ocul Pharmacol Ther 13 1 1997 61 67
7. P.E. Romano, and J.P. Donovan Management of progressive school myopia with topical atropine eyedrops and photochromic bifocal spectacles Binocul Vis Strabismus Q 15 3 2000 257 260
8. R.H. Kennedy, J.A. Dyer, and M.A. Kennedy et al. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students Binocul Vis Strabismus Q 15 3 suppl 2000 281 304
9. M.F. Chiang, A. Kouzis, R.W. Pointer, and M.X. Repka Treatment of childhood myopia with atropine eyedrops and bifocal spectacles Binocul Vis Strabismus Q 16 3 2001 209 215
10. L.A. Syniuta, and S.J. Isenberg Atropine and bifocals can slow the progression of myopia in children Binocul Vis Strabismus Q 16 3 2001 203 208
11. J.J. Lee, P.C. Fang, and I.H. Yang et al. Prevention of myopia progression with 0.05% atropine solution J Ocul Pharmacol Ther 22 1 2006 41 46
12. D.S. Fan, D.S. Lam, and C.K. Chan et al. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study Jpn J Ophthalmol 51 1 2007 27 33
13. M.Y. Yen, J.H. Liu, S.C. Kao, and C.H. Shiao Comparison of the effect of atropine and cyclopentolate on myopia Ann Ophthalmol 21 5 1989 180 182 187
14. Y.F. Shih, C.H. Chen, and A.C. Chou et al. Effects of different concentrations of atropine on controlling myopia in myopic children J Ocul Pharmacol Ther 15 1 1999 85 90
15. Y.F. Shih, C.K. Hsiao, and C.J. Chen et al. An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression Acta Ophthalmol Scand 79 3 2001 233 236
16. W.H. Chua, V. Balakrishnan, and Y.H. Chan et al. Atropine for the treatment of childhood myopia Ophthalmology 113 12 2006 2285 2291
17. C.K. Liang, T.Y. Ho, and T.C. Li et al. A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial Complement Ther Med 16 6 2008 305 310
18. L. Tong, X.L. Huang, and A.L. Koh et al. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine Ophthalmology 116 3 2009 572 579
19. A. Chia, W.H. Chua, and Y.B. Cheung et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (ATOM2) Ophthalmology 119 2 2012 347 354
20. R.L. Williams A note on robust variance estimation for cluster-correlated data Biometrics 56 2 2000 645 646
21. V.A. Barathi, and R.W. Beuerman Molecular mechanism of muscarinic receptors in mouse scleral fibroblast: prior to and after induction of experimental myopia with atropine treatment Mol Vis 17 2011 680 692
22. J. Qu, X. Zhou, and R. Xie et al. The presence of m1 to m5 receptors in human sclera: evidence of the sclera as potential sites of action for muscarinic receptor antagonist Curr Eye Res 31 7-8 2006 587 597
23. F. Mitchelson Muscarinic receptor agonists and antagonist: effects on ocular function Handb Exp Pharmacol 208 2012 263 298
24. V.A. Barathi, S.R. Weon, and R.W. Beuerman Expression of muscarinic receptors in human and mouse sclera and their role in regulation of scleral fibroblast proliferation Mol Vis 15 2009 1277 1293
25. V.A. Barathi, S.R. Weon, Q.S. Tan, K.J. Lin, L. Tong, and R.W. Beuerman Transglutaminases (TGs) in ocular and periocular tissues; effect of muscarinic agents on TGs in scleral fibroblast PloS One 6 2011 e18326
26. N.A. McBrien, B. Arumugam, A. Gentle, A. Chow, and S. Sahebjada The M4 muscarinic antagonist MT-3 inhibits myopia in chick: evidence for site of action Ophthal Physiol Opt 31 5 2011 529 539